Soheila Dolatabadi

2PUBLICATIONS
5CO-AUTHORS
Molecular targetsSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Mar 25, 2022
Different HSP90 Inhibitors Exert Divergent Effect on Myxoid Liposarcoma In Vitro and In Vivo.

Christoffer Vannas, Lisa Andersson, Soheila Dolatabadi

|Jan 17, 2019
JAK-STAT signalling controls cancer stem cell properties including chemotherapy resistance in myxoid liposarcoma.

Soheila Dolatabadi, Emma Jonasson, Malin Lindén

Pageof 1